摘要
目的:观察米非司酮联合甲氨蝶呤保守治疗宫外孕的疗效。方法:2016年6月-2018年12月收治宫外孕患者60例,按治疗方法不同分为两组,各30例。对照组给予甲氨蝶呤治疗;观察组给予米非司酮联合甲氨蝶呤治疗。比较两组治疗效果。结果:观察组治疗总有效率高于对照组,且临床症状消失时间及血清β-人绒毛膜促性腺激素(β-hCG)水平恢复正常时间均优于对照组,差异有统计学意义(P<0.05)。结论:宫外孕保守治疗以米非司酮联合甲氨蝶呤为优选方案,临床可行性较高。
Objective:To observe the efficacy of mifepristone combined with methotrexate in the conservative treatment of ectopic pregnancy.Methods:From June 2016 to December 2018,60 patients with ectopic pregnancy were selected,and they were divided into two groups according to the different treatment methods with 30 cases in each group.The control group was treated with methotrexate.The observation group was treated with mifepristone and methotrexate.The therapeutic effects between the two groups was compared.Results:The total therapeutic effective rate of the observation group was higher than the control group,and the time for the disappearance of clinical symptoms and the time for the serum level of β-hCG to return to normal were both better than the control group,the differences were statistically significant(P<0.05).Conclusion:Mifepristone combined with methotrexate is the optimal conservative treatment for ectopic pregnancy,and the clinical feasibility is higher.
作者
宋敏
Song Min(Department of Obstetrics,the People's Hospital of Pingyuan County,Dezhou City,Shandong Dezhou 253100)
出处
《中国社区医师》
2020年第21期11-11,13,共2页
Chinese Community Doctors
关键词
宫外孕
保守治疗
米非司酮
甲氨蝶呤
Ectopic pregnancy
Conservative treatment
Mifepristone
Methotrexate
